Navigation Links
BioStorage Technologies Expands its Service Offering to Include Advanced Bioprocessing Solutions
Date:8/9/2012

INDIANAPOLIS, Aug. 9, 2012 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, including storage, cold chain logistics and virtual sample intelligence, announced today that the company has developed a strategic and innovative Bioprocessing Solutions alliance with RUCDR Infinite Biologics.  The alliance provides the bioscience industry with an integrated, state-of-the-art scientific approach and technology infrastructure for the delivery of advanced sample bioprocessing and biobanking solutions. 

Good storage practices are critical to maintaining the integrity of biological samples; therefore an integrated sample lifecycle strategy connecting sample collection, transportation and storage to the bioprocessing of samples allows for maximum optimization of preserved biological samples. With this in mind, this new alliance extends BioStorage Technologies capabilities by incorporating a broad spectrum of advanced bioprocessing techniques, such as nucleic acid sample preparation services, genetic and genomic services, cell services, bioinformatics and analysis solutions, with its industry-leading sample storage processes.

"As a global leader in comprehensive sample management solutions, it was a natural progression to also offer our clients advanced bioprocessing solutions. With the addition of these services, we can extend stored samples into renewable biological resources and optimize the value of these assets for future research by reducing study costs, minimizing risk of sample loss and speeding new drugs to market faster," said Gregory Swanberg, CEO, BioStorage Technologies. "The scientific and technical bioprocessing solutions expertise of RUCDR Infinite Biologics combined with our leadership in sample management best practices allow us to deliver a complete and integrated sample lifecycle solutions approach and expands our capabilities to support p
'/>"/>

SOURCE BioStorage Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioStorage Technologies Appoints New Member to Board of Directors
2. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
3. BioStorage Technologies Partners with Susan G. Komen for the Cure Tissue Bank at IU Simon Cancer Center to Raise Money and Awareness for Breast Cancer Research
4. BioStorage Technologies to Host Global Sample Management Workshop at Partnerships in Clinical Trials
5. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
6. BioStorage Technologies Continues Global Growth; Announces Strategic Expansion Into Asia Pacific and New General Manager APAC
7. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
8. UV Flu Technologies Expands Its International Footprint
9. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
10. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
11. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry is ... with a focus on the Chinese situation. Major companies included in the propanol market ... Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides a ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... ... Datafarm for production of Hybrid eCTD submissions to Health Canada. Datafarm’s announcement comes on ... that, effective immediately, sponsor companies may submit Hybrid eCTD regulatory submissions for New Drug ... ...
... 5, 2009 Complete Genomics, a third-generation human genome ... the journal Science describing its proprietary DNA ... complete human genomes. The consumables cost for these three ... from $8,005 for 87x coverage to $1,726 for 45x ...
... (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that ... Merriman Curhan Ford,s 6th annual Investor Summit on November 10, ... York City. Mr. Docherty will provide an overview of ... Alpha-2b. The slide show portion of the presentation will ...
Cached Biology Technology:Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... July 07, 2015 ... addition of the "Biometrics for Banking; Market ... report to their offering. The ... to this growth and the forecast is that ... revenue for companies involved in delivering biometric systems ...
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... Starting in May 2009, Springer will publish the ... of the Japanese Society of Biorheology. This ... physiologists and materials scientists to exchange and discuss ... Journal of Biorheology covers the science and ...
... NEW YORK (April 23, 2009) The Wildlife Conservation ... reefs off East Africa are unusually resilient to climate ... of geophysical factors. WCS announced the results of ... which is meeting this week in Phuket, Thailand. ...
... Marine scientists say they are astonished at the spectacular recovery ... Park from a devastating coral bleaching event in 2006. ... bleaching in the Keppel Islands, in the southern part of ... a single species of seaweed an event that can ...
Cached Biology News:Springer and Japanese Society of Biorheology to work together 2'Super reefs' fend off climate change, study says 2Reef boom beats doom 2
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... proteases/caspases initiates apoptosis in mammalian cells. ... provides a simple and convenient means for ... in intact cells. The assay utilizes ... linked to rhodamine 110 (D2R), a reported ...
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
Biology Products: